Drug Interactions and Interindividual Variability of Ciclosporin Metabolism in the Small Intestine

Pharmacology

Volumn 52, Issue 3, 1996, Pages 159-168

  Lampen, Alfons ^a   Christians, Uwe ^a   Bader, Augustinus ^a   Hackbarth, Ingelore ^a   Sewing, Karl Friedrich ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Bioavailability; Ciclosporin; Cytochrome P450 3A; Small intestinal metabolism

Indexed keywords

BROMOCRIPTINE; CORTICOSTERONE; CYCLOSPORIN A; CYTOCHROME P450; DEXAMETHASONE; DILTIAZEM; DRUG METABOLITE; DRUG METABOLIZING ENZYME; ENZYME ANTIBODY; ERGOTAMINE; ERYTHROMYCIN; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; JOSAMYCIN; NIFEDIPINE; PROGESTERONE; RAPAMYCIN; TACROLIMUS; TROLEANDOMYCIN; VERAPAMIL; XENOBIOTIC AGENT;

ADULT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; DRUG ANALYSIS; DRUG BIOAVAILABILITY; DRUG INHIBITION; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; MICROSOME; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SMALL INTESTINE; SWINE;

EID: 0029960192     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139380     Document Type: Article

References (39)

1. European Multicentre Trial Group: Cyclosporine in cadaveric renal transplantation: One-year follow-up of a multicentre trial. Lancet 1983; ii:986-989.
2. Kalian BD: Cyclosporine. N Engl J Med 1989;321:1725-1738.
3. Faulds D, Goa KL, Benefield P: Cyclosporin: A review of its pharmacodynamic properties, and therapeutic use in immunregulatory disorders. Drugs 1993;45:953-1040.
4. Kronbach T, Fischer V. Meyer UA: Cyclosporine metabolism in human liver: Identification of a cytochrome P450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Thcr 1988;43:630-635.
5. Christians U, Sewing KF: Cyclosporin metabolism in transplant patients. Pharmacol Thcr 1993:57: 291-345.
6. Burckart GJ, Starzl TE, Venkatra-manan R, Hashem H, Wong L. Wang P. Makowka L, Zeevi A, Ptachcinski RJ. Knapp JE, Iwatsuki S, Esquivel C, Sanghvi A, Van Thiel DH: Excretion of cyclosporine and its metabolites in human bile. Transplant Proc 1986;18:46-49.
7. Kolars JC, Stetson PL, Rush BD. Ruwart MJ. Schmiedlin-Ren P. Duell EA. Voorhees JJ, Watkins PB: Cyclosporin A metabolism by P450IIIA in rat enterocytcs: Another determinant of oral bioavailability? Transplantation 1992;53:596-602.
8. Tija JF. Webber IR. Back DJ: Cyclosporin metabolism by gastrointestinal mucosa. Br J Clin Pharmacol 1991;31:344-346.
9. Webber JR. Peters WHM. Back DJ: Cyclosporin metabolism by human gastrointestinal mucosal micro-somes. J Pharmacol 1992:33:661-664.
10. Kolars JC, Awni WM. Merion RM, Watkins PB: First-pass metabolism of cyclosporin by the gut. Lancet 1991:338:1488-1490.
11. Watkins PB: Role of cytochromes P450 in drug metabolism and hepa-totoxicity. Semin Liver Dis 1990:10: 235-250.
12. Gupta SK. Bakran A, Johnson RW, Rowland M: Erythromycin enhances the absorption of cyclosporine. Br J Clin Pharmacol !988;25: 401-402.
13. Herbert MF. Roberts JP, Prueksari tanont T, Benet LZ: Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Thcr 1992:52:453-457.
14. Rowland M, Gupta SK: Cyclospo-rin-phenytoin interaction: Re-evaluation using metabolite data. Br J Clin Pharmacol 1987;24:329-344.
15. Portcous JW, Fumeaux HM. Pearson FK. Lake CM. Morison A: Poly adenosine diphosphate ribose synthetase activity in nuclei of dividing but differentiating intestinal epithelial cells. Biochcm J 1979:180:455-463.
16. Pinkus LM: Separation and use of enterocytes; in Jakoby WB (ed): Methods in Enzymology. New York. Academic Press. 1981, vol 77, pp 154-162.
17. Guengcrich FP: Microsomal enzymes involved in toxicology: Analysis and separation; in Hayes AW (ed): Principles and Methods of Toxicology. New York. Raven Press. 1982. pp 609-637.
18. Smith PK, Krohn RI, Hermanson GT. Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ. Klcnk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150:76-85.
19. Omura T, Sato R: The carbon monoxide-binding pigment of liver mi-crosomes. I. Evidence for its hemo-protcin nature. J Biol Chem 1964; 239:2370-2378.
20. Estabrook RW, Werringloer J: The measurement of difference spectra: Application to the cytochromes of microsomes. Meth Enzymol 1978; 52:212-220.
21. Sattler M, Guengerich FP, Yun CY, Christians U. Sewing KF: Cytochrome P450-3A4 is responsible for biotransformation of FK506 and ra-pamycin in man and rat. Drug Mc-tabDispos 1992;20:753-761.
22. Christians U. Zimmer KO. Woni-geit K. Maurer G, Sewing KF: Liquid-chromatographic measurement of cyclosporin A and its metabolites in blood, bile and urine. Clin Chem 1988;34:34-39.
23. Holt DW, Marsden JT, Johnson A: Quality assessment of cyclosporine measurements: Comparison of current methods. Transplant Proc 1990;22:1234-1239.
24. Christians U. Strohmeycr S, Kow-natzki R. Schiebel HM, Bleck J, Grcipel J, Kohlhaw K, Schottmann R. Sewing KF: Investigations on the metabolic pathways of cyclosporine. I. Excretion of cyclosporine and its metabolites in human bile - isolation of 12 new cyclosporine metabolites. Xenobiotica 1991:21:1185-1198.
25. Butler MA, Iwasaki M. Guengerich FP, Kadlubar FF: Human cytochrome P-450pa (P-450IA2). the phenacetin O-deethylase, is primarily responsible for the hepatic 3-de-mcthylation of caffeine and N-oxi-dation of carcinogenic arylamines. Proc Natl Acad Sei USA 1989:86: 7696-7700.
26. Guengerich FP, Kim DH, Iwasaki M: Role of human cytochrome P-450 I1E1 in the oxidation of several low molecular weight cancer suspects. Chem Res Toxicol 1991:4: 168-179.
27. Shimada T, Misono KS. Guengerich FP: Human liver microsomal cytochrome P-450 mephenytoin 4-hy-droxylase, a prototype of genetic polymorphism in oxidative drug metabolism. J Biol Chem 1986:261: 909-921.
28. Guengerich FP, Martin MV, Beaune PH. Krcmcrs P, Wolff T, Waxman DJ: Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 1986; 261:5051-5060.
29. Watkins PB. Wrighton SA. Schuetz EG, Molowa DT, Guzelian PS: Identification of glucocorticoid-inducible cytochrome P-450 in the intestinal mucosa of rats and man. J Clin Invest 1987;80:1029-1036.
30. Pichard L. Fabre I, Fabrc G. Domerque J, Saint Aubert B, Mourad G, Maurel P: Cyclosporin A drug interactions: Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and liver microsomes. Drug Metab Dis-pos 1990:18:595-606.
31. Gorski JC. Hall SD, Jones DR. Van-denbranden M. Wrighton SA: Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochcm Pharmacol 1994;47:1643-1653.
32. Ochs HR. Grenblatt DJ, Eichelkraut W. Bakker C. Göbel R. Hahn N: Hepaticvs. gastrointestinal presystemic extraction of oral midazolam and fiurazepam. J Pharmacol Exp Ther 1987;243:852-856.
33. Bargctzi MJ. Aoyama T, Gonzalez FJ, Meyer UA: Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clin Pharmacol Ther 1989;46:521-527.
34. Andersson T, Miners JO, Veronese ME. Birkelt DJ: Identification ofthc human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism. Br J Clin Pharmacol 1994;37:597-604.
35. Christians U, Kohlhaw K, Essel-mann H. Siirig T, Luv M. Kaltcflei-tcr M. Beyrau R. Linck A, Ringe B, Oellerich M, Sewing KF: The yin and yang of lidocaine and cyclosporine metabolism in liver graft recipients. Transplant Proc 1994;26: 2827-2828.
36. Kolars JC. Lown KS, Schmiedlin-Ren P. Ghosh M, Fang C. Wrighton SA, Merion RM, Watkins PB: CYP3A gene expression in human gut epithelium. Pharmacogenetics 1994:4:247-259.
37. Drcwc J. Beglingcr C, Kissel T: The absorption of cyclosporin in the human gastrointestinal tract. Br J Clin Pharmacol 1992;33:39-43.
38. Lown KS. Kolars JC. Thummel KE. Barnett JL, Kunze KL, Wrighton SA. Watkins PB: Interpatient heterogeneity in expression of cyp3A4 and cyp3A5 in small bowel. Drug Metab Dispos 1994;22:947-952.
39. Hunt CM. Westerkam WR. Stave GM: Effect of age and gender on the activity of hepatic cytochrome P450 3A. Biochem Pharmacol 1992:22: 275-283.